Neoadjuvant chemotherapy for gastric cancer. Has the time to decelerate the enthusiasm passed us by?
D2-gastrectomy
Locally advanced gastric cancer
Neoadjuvant chemotherapy
Preoperative chemotherapy
Journal
Seminars in oncology
ISSN: 1532-8708
Titre abrégé: Semin Oncol
Pays: United States
ID NLM: 0420432
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
05
08
2019
revised:
08
07
2020
accepted:
08
07
2020
pubmed:
8
8
2020
medline:
23
1
2021
entrez:
8
8
2020
Statut:
ppublish
Résumé
Neoadjuvant therapy for locally advanced gastric cancer is a treatment option well recognized in international guidelines. However, neither completed randomized trials nor ongoing studies (will) offer definitive answers about the efficacy of neoadjuvant therapy. With extensive experience confirming the safety and some efficacy for this approach most current studies are focused on identifying the best preoperative treatment regimen. We try to clarify if is really the time to slow down the enthusiasm about neoadjuvant approach.
Identifiants
pubmed: 32758372
pii: S0093-7754(20)30080-4
doi: 10.1053/j.seminoncol.2020.07.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-360Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have nothing to disclose.